Menu
GeneBe

rs142011700

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_032119.4(ADGRV1):c.1839+7G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00181 in 1,575,870 control chromosomes in the GnomAD database, including 40 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0087 ( 22 hom., cov: 31)
Exomes 𝑓: 0.0011 ( 18 hom. )

Consequence

ADGRV1
NM_032119.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00001590
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.469
Variant links:
Genes affected
ADGRV1 (HGNC:17416): (adhesion G protein-coupled receptor V1) This gene encodes a member of the G-protein coupled receptor superfamily. The encoded protein contains a 7-transmembrane receptor domain, binds calcium and is expressed in the central nervous system. Mutations in this gene are associated with Usher syndrome 2 and familial febrile seizures. Several alternatively spliced transcripts have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 5-90629546-G-A is Benign according to our data. Variant chr5-90629546-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 46297.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-90629546-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00875 (1332/152236) while in subpopulation AFR AF= 0.0292 (1212/41524). AF 95% confidence interval is 0.0278. There are 22 homozygotes in gnomad4. There are 634 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd at 21 AR,Digenic gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ADGRV1NM_032119.4 linkuse as main transcriptc.1839+7G>A splice_region_variant, intron_variant ENST00000405460.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ADGRV1ENST00000405460.9 linkuse as main transcriptc.1839+7G>A splice_region_variant, intron_variant 1 NM_032119.4 P1Q8WXG9-1
ADGRV1ENST00000640109.1 linkuse as main transcriptn.1942G>A non_coding_transcript_exon_variant 9/95
ADGRV1ENST00000504142.2 linkuse as main transcriptn.605+7G>A splice_region_variant, intron_variant, non_coding_transcript_variant 5

Frequencies

GnomAD3 genomes
AF:
0.00874
AC:
1330
AN:
152118
Hom.:
21
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0292
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00570
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.00670
GnomAD3 exomes
AF:
0.00258
AC:
595
AN:
230640
Hom.:
11
AF XY:
0.00204
AC XY:
256
AN XY:
125632
show subpopulations
Gnomad AFR exome
AF:
0.0303
Gnomad AMR exome
AF:
0.00254
Gnomad ASJ exome
AF:
0.00186
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000368
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000321
Gnomad OTH exome
AF:
0.00180
GnomAD4 exome
AF:
0.00107
AC:
1519
AN:
1423634
Hom.:
18
Cov.:
25
AF XY:
0.000932
AC XY:
660
AN XY:
707970
show subpopulations
Gnomad4 AFR exome
AF:
0.0312
Gnomad4 AMR exome
AF:
0.00273
Gnomad4 ASJ exome
AF:
0.00166
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000849
Gnomad4 FIN exome
AF:
0.0000195
Gnomad4 NFE exome
AF:
0.000176
Gnomad4 OTH exome
AF:
0.00255
GnomAD4 genome
AF:
0.00875
AC:
1332
AN:
152236
Hom.:
22
Cov.:
31
AF XY:
0.00852
AC XY:
634
AN XY:
74436
show subpopulations
Gnomad4 AFR
AF:
0.0292
Gnomad4 AMR
AF:
0.00569
Gnomad4 ASJ
AF:
0.000865
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000943
Gnomad4 NFE
AF:
0.000206
Gnomad4 OTH
AF:
0.00663
Alfa
AF:
0.00344
Hom.:
2
Bravo
AF:
0.0103
Asia WGS
AF:
0.00289
AC:
10
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Likely benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoAug 27, 2013- -
Benign, criteria provided, single submitterclinical testingGeneDxNov 06, 2017This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 26, 2012c.1839+7G>A in intron 9 of GPR98: This variant is not expected to have clinical significance because it has been identified in 2.8% (82/2974) of African America n chromosomes in a broad population by the NHLBI Exome sequencing project (http: //evs.gs.washington.edu/EVS/; rs142011700). -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
not provided Benign:3
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsFeb 22, 2017- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesSep 21, 2023- -
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
Usher syndrome type 2C Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
Cadd
Benign
1.5
Dann
Benign
0.31

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000016
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs142011700; hg19: chr5-89925363; API